rel-Latanoprost acid

Overview

rel-Latanoprost acid is a relative configuration of Latanoprost acid ( HY-113756A ). Latanoprost acid , an analog of prostaglandin (PG) F2α, is an selective prostanoid receptor ( FP ) agonist that specifically activates the FP-PG receptor. Latanoprost acid inhibits RANKL-induced osteoclastgenesis and function by inhibiting ERK , AKT , JNK , and p38 cascade, following by the c-fos/NFATc1 pathway. Latanoprost acid is a medication which works to lower pressure inside the eyes.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Akt | Products > Signaling Pathways > JNK | Products > Signaling Pathways > p38 MAPK | Products > Signaling Pathways > Drug Derivative | Products > Signaling Pathways > Prostaglandin Receptor | Products > Signaling Pathways > ERK

Product Information

• Catalog No.: HY-113756B
• CAS No.: 2699713-95-4
• Molecular Formula: C23H34O5
• Molecular Weight: 390.51
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source